A rating of 98 places Poseida Therapeutics Inc (PSTX) near the top of the biotechnology industry according to InvestorsObserver. Poseida Therapeutics Inc.’s score of 98 means it scores above 98% of industry stocks. Poseida Therapeutics Inc also received an overall rating of 88, which puts it above 88% of all stocks. Biotechnology is ranked 34th out of 148 industries.
What do these notes mean?
Finding the best stocks to invest in can be difficult. There are thousands of options and it can be confusing to know what really constitutes great value. InvestorsObserver lets you choose from eight unique metrics to display the top industries and top performing stocks within that industry. A score of 88 would be higher than 88% of all actions. Our proprietary rating system captures technical factors, fundamental analysis and the opinions of Wall Street analysts. This makes InvestorsObserverThe overall rating of is a great way to get started, regardless of your investing style. Scores ranked in percentiles are also easy to understand. A score of 100 is high and a 0 is low. There’s no need to try to remember what’s “good” for a bunch of complicated ratios, just pay attention to the higher numbers.
What’s going on with Poseida Therapeutics Inc stock today?
Poseida Therapeutics Inc (PSTX) stock is trading at $7.22 at 3:09 p.m. on Wednesday, January 25, down -$0.27, or -3.6% from the previous closing price of 7 $.49. The stock has traded between $6.82 and $7.58 so far today. Today the volume is low. So far, 323,691 shares have been traded with an average volume of 502,297 shares. Click here for the full Poseida Therapeutics Inc. stock report.
Stay in the know
Subscribe to our daily morning update newsletter and never miss market news, moves and more.